Cargando…
Mutation Screening of mtDNA Combined Targeted Exon Sequencing in a Cohort With Suspected Hereditary Optic Neuropathy
PURPOSE: Leber hereditary optic neuropathy (LHON) and autosomal dominant optic atrophy (ADOA) are the two commonest forms of hereditary optic neuropathy. The aim of this study was to comprehensively investigate the incidence and spectrum of mutations in patients with suspected hereditary optic neuro...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422818/ https://www.ncbi.nlm.nih.gov/pubmed/32855858 http://dx.doi.org/10.1167/tvst.9.8.11 |
_version_ | 1783570074837188608 |
---|---|
author | Li, Jian-Kang Li, Wei Gao, Feng-Juan Qu, Shou-Fang Hu, Fang-Yuan Zhang, Sheng-Hai Li, Li-Li Wang, Zi-Wei Qiu, Yong Wang, Lu-Sheng Huang, Jie Wu, Ji-Hong Chen, Fang |
author_facet | Li, Jian-Kang Li, Wei Gao, Feng-Juan Qu, Shou-Fang Hu, Fang-Yuan Zhang, Sheng-Hai Li, Li-Li Wang, Zi-Wei Qiu, Yong Wang, Lu-Sheng Huang, Jie Wu, Ji-Hong Chen, Fang |
author_sort | Li, Jian-Kang |
collection | PubMed |
description | PURPOSE: Leber hereditary optic neuropathy (LHON) and autosomal dominant optic atrophy (ADOA) are the two commonest forms of hereditary optic neuropathy. The aim of this study was to comprehensively investigate the incidence and spectrum of mutations in patients with suspected hereditary optic neuropathy by combining mitochondrial DNA (mtDNA) genome-wide and targeted exon sequencing. METHODS: A cohort of 1101 subjects were recruited to participate in the study, comprising 177 families (177 probands and their family members, a total of 537 subjects, including 254 patients) and 164 sporadic cases with suspected hereditary optic neuropathy, and 400 unrelated control subjects for genetic analysis: all subjects (including control subjects) underwent a comprehensive ophthalmologic examination and were subjected to sequencing analysis of mtDNA genome-wide and targeted exon. Overall, targeted exon sequencing was used to screen 792 genes associated with common hereditary eye diseases, and the mtDNA genome-wide were screened by next-generation sequencing. RESULTS: We found variants detected in 168 (40.2%, 168/418) of the 418 patients screened. Among these, 132 cases (78.6%, 132/168) were detected with known LHON disease-causing mtDNA variants; 40 cases (23.8%, 40/168) were detected with nuclear DNA (ntDNA) variants, which included 36 cases (21.4%, 36/168) with detected OPA1 mutations, 4 patients (2.4%, 4/168) with detected OPA3 mutations, and 2 patients (1.2%, 2/168) with detected TMEM126A homozygous mutation. Coexistence variation (mtDNA/mtDNA [n = 16], ntDNA/ntDNA [n = 4], mtDNA/ntDNA [n = 7]) was found in 27 patients (16.4%, 27/165), including mtDNA/ntDNA coexistence variation that was detected in seven patients. Among these ntDNA mutations, 38 distinct disease-causing variants, including autosomal recessive heterozygous mutations, were detected, which included 22 novel variants and two de novo variants. Total haplogroup distribution showed that 34.5% (29/84) and 28.6% (24/84) of the affected subjects with m.11778G>A belonged to haplogroup D and M, with a high frequency of subhaplogroups D4, D5, and M7. CONCLUSIONS: The LHON-mtDNA mutations are the commonest genetic defects in this Chinese cohort, followed by the OPA1 mutations. To our knowledge, this is the first comprehensive study of LHON, ADOA, and autosomal recessive optic atrophy combined with mtDNA genome-wide and targeted exon sequencing, as well as haplogroup analysis, in a large cohort of Chinese patients with suspected hereditary optic neuropathy. Our findings provide a powerful basis for genetic counseling in patients with suspected hereditary optic neuropathy. TRANSLATIONAL RELEVANCE: We applied mtDNA genome-wide sequencing combined with panel-based targeted exon sequencing to explore the pathogenic variation spectrum and genetic characteristics of patients with suspected hereditary optic neuropathy, providing a comprehensive research strategy for clinical assistant diagnosis, treatment, and genetic counseling. |
format | Online Article Text |
id | pubmed-7422818 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Association for Research in Vision and Ophthalmology |
record_format | MEDLINE/PubMed |
spelling | pubmed-74228182020-08-26 Mutation Screening of mtDNA Combined Targeted Exon Sequencing in a Cohort With Suspected Hereditary Optic Neuropathy Li, Jian-Kang Li, Wei Gao, Feng-Juan Qu, Shou-Fang Hu, Fang-Yuan Zhang, Sheng-Hai Li, Li-Li Wang, Zi-Wei Qiu, Yong Wang, Lu-Sheng Huang, Jie Wu, Ji-Hong Chen, Fang Transl Vis Sci Technol Article PURPOSE: Leber hereditary optic neuropathy (LHON) and autosomal dominant optic atrophy (ADOA) are the two commonest forms of hereditary optic neuropathy. The aim of this study was to comprehensively investigate the incidence and spectrum of mutations in patients with suspected hereditary optic neuropathy by combining mitochondrial DNA (mtDNA) genome-wide and targeted exon sequencing. METHODS: A cohort of 1101 subjects were recruited to participate in the study, comprising 177 families (177 probands and their family members, a total of 537 subjects, including 254 patients) and 164 sporadic cases with suspected hereditary optic neuropathy, and 400 unrelated control subjects for genetic analysis: all subjects (including control subjects) underwent a comprehensive ophthalmologic examination and were subjected to sequencing analysis of mtDNA genome-wide and targeted exon. Overall, targeted exon sequencing was used to screen 792 genes associated with common hereditary eye diseases, and the mtDNA genome-wide were screened by next-generation sequencing. RESULTS: We found variants detected in 168 (40.2%, 168/418) of the 418 patients screened. Among these, 132 cases (78.6%, 132/168) were detected with known LHON disease-causing mtDNA variants; 40 cases (23.8%, 40/168) were detected with nuclear DNA (ntDNA) variants, which included 36 cases (21.4%, 36/168) with detected OPA1 mutations, 4 patients (2.4%, 4/168) with detected OPA3 mutations, and 2 patients (1.2%, 2/168) with detected TMEM126A homozygous mutation. Coexistence variation (mtDNA/mtDNA [n = 16], ntDNA/ntDNA [n = 4], mtDNA/ntDNA [n = 7]) was found in 27 patients (16.4%, 27/165), including mtDNA/ntDNA coexistence variation that was detected in seven patients. Among these ntDNA mutations, 38 distinct disease-causing variants, including autosomal recessive heterozygous mutations, were detected, which included 22 novel variants and two de novo variants. Total haplogroup distribution showed that 34.5% (29/84) and 28.6% (24/84) of the affected subjects with m.11778G>A belonged to haplogroup D and M, with a high frequency of subhaplogroups D4, D5, and M7. CONCLUSIONS: The LHON-mtDNA mutations are the commonest genetic defects in this Chinese cohort, followed by the OPA1 mutations. To our knowledge, this is the first comprehensive study of LHON, ADOA, and autosomal recessive optic atrophy combined with mtDNA genome-wide and targeted exon sequencing, as well as haplogroup analysis, in a large cohort of Chinese patients with suspected hereditary optic neuropathy. Our findings provide a powerful basis for genetic counseling in patients with suspected hereditary optic neuropathy. TRANSLATIONAL RELEVANCE: We applied mtDNA genome-wide sequencing combined with panel-based targeted exon sequencing to explore the pathogenic variation spectrum and genetic characteristics of patients with suspected hereditary optic neuropathy, providing a comprehensive research strategy for clinical assistant diagnosis, treatment, and genetic counseling. The Association for Research in Vision and Ophthalmology 2020-07-08 /pmc/articles/PMC7422818/ /pubmed/32855858 http://dx.doi.org/10.1167/tvst.9.8.11 Text en Copyright 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. |
spellingShingle | Article Li, Jian-Kang Li, Wei Gao, Feng-Juan Qu, Shou-Fang Hu, Fang-Yuan Zhang, Sheng-Hai Li, Li-Li Wang, Zi-Wei Qiu, Yong Wang, Lu-Sheng Huang, Jie Wu, Ji-Hong Chen, Fang Mutation Screening of mtDNA Combined Targeted Exon Sequencing in a Cohort With Suspected Hereditary Optic Neuropathy |
title | Mutation Screening of mtDNA Combined Targeted Exon Sequencing in a Cohort With Suspected Hereditary Optic Neuropathy |
title_full | Mutation Screening of mtDNA Combined Targeted Exon Sequencing in a Cohort With Suspected Hereditary Optic Neuropathy |
title_fullStr | Mutation Screening of mtDNA Combined Targeted Exon Sequencing in a Cohort With Suspected Hereditary Optic Neuropathy |
title_full_unstemmed | Mutation Screening of mtDNA Combined Targeted Exon Sequencing in a Cohort With Suspected Hereditary Optic Neuropathy |
title_short | Mutation Screening of mtDNA Combined Targeted Exon Sequencing in a Cohort With Suspected Hereditary Optic Neuropathy |
title_sort | mutation screening of mtdna combined targeted exon sequencing in a cohort with suspected hereditary optic neuropathy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422818/ https://www.ncbi.nlm.nih.gov/pubmed/32855858 http://dx.doi.org/10.1167/tvst.9.8.11 |
work_keys_str_mv | AT lijiankang mutationscreeningofmtdnacombinedtargetedexonsequencinginacohortwithsuspectedhereditaryopticneuropathy AT liwei mutationscreeningofmtdnacombinedtargetedexonsequencinginacohortwithsuspectedhereditaryopticneuropathy AT gaofengjuan mutationscreeningofmtdnacombinedtargetedexonsequencinginacohortwithsuspectedhereditaryopticneuropathy AT qushoufang mutationscreeningofmtdnacombinedtargetedexonsequencinginacohortwithsuspectedhereditaryopticneuropathy AT hufangyuan mutationscreeningofmtdnacombinedtargetedexonsequencinginacohortwithsuspectedhereditaryopticneuropathy AT zhangshenghai mutationscreeningofmtdnacombinedtargetedexonsequencinginacohortwithsuspectedhereditaryopticneuropathy AT lilili mutationscreeningofmtdnacombinedtargetedexonsequencinginacohortwithsuspectedhereditaryopticneuropathy AT wangziwei mutationscreeningofmtdnacombinedtargetedexonsequencinginacohortwithsuspectedhereditaryopticneuropathy AT qiuyong mutationscreeningofmtdnacombinedtargetedexonsequencinginacohortwithsuspectedhereditaryopticneuropathy AT wanglusheng mutationscreeningofmtdnacombinedtargetedexonsequencinginacohortwithsuspectedhereditaryopticneuropathy AT huangjie mutationscreeningofmtdnacombinedtargetedexonsequencinginacohortwithsuspectedhereditaryopticneuropathy AT wujihong mutationscreeningofmtdnacombinedtargetedexonsequencinginacohortwithsuspectedhereditaryopticneuropathy AT chenfang mutationscreeningofmtdnacombinedtargetedexonsequencinginacohortwithsuspectedhereditaryopticneuropathy |